Evidence map›Paper›PMID 31184997›Full record

ArticleJCI insight2019

Transcriptome profiling reveals Th2 bias and identifies endogenous itch mediators in poison ivy contact dermatitis.

Boyi Liu, Yan Tai, Boyu Liu, Ana I Caceres, Chengyu Yin, Sven-Eric Jordt

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Neuroimmune interactions in atopic and allergic contact dermatitis.The Journal of allergy and clinical immunology · 2023
    Review
  10. Article
  11. Article
  12. Interactions of the Neuro‒Immune‒Stromal Triad in Itch.The Journal of investigative dermatology · 2022
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Itch in Allergic Contact Dermatitis.Frontiers in allergy · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Boyi LiuDepartment of Neurobiology and Acupuncture Research, The Third Clinical Medical College, Zhejiang Chinese Medical University, Key Laboratory of Acupuncture and Neurology of Zhejiang Province, Hangzhou, China.
Yan TaiAcademy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Boyu LiuDepartment of Neurobiology and Acupuncture Research, The Third Clinical Medical College, Zhejiang Chinese Medical University, Key Laboratory of Acupuncture and Neurology of Zhejiang Province, Hangzhou, China.
Ana I CaceresDepartment of Anesthesiology, Duke University School of Medicine, Durham, North Carolina, USA.
Chengyu YinDepartment of Neurobiology and Acupuncture Research, The Third Clinical Medical College, Zhejiang Chinese Medical University, Key Laboratory of Acupuncture and Neurology of Zhejiang Province, Hangzhou, China.
Sven-Eric JordtDepartment of Anesthesiology, Duke University School of Medicine, Durham, North Carolina, USA.
The Third Affiliated Hospital of Zhejiang Chinese Medical University · CNDuke University · USZhejiang Chinese Medical University · CN

Funding

Mechanisms of Itch in Poison Ivy-Induced Allergic Contact DermatitisR21AR070554 · NIAMS · DUKE UNIVERSITY · PI JORDT, SVEN-ERIC · 2016 to 2017
$385k
NIAMS NIH HHS R21 AR070554
6 · The paper itself

Abstract

In the United States, poison ivy exposure is the most common naturally occurring allergen to cause allergic contact dermatitis (ACD). The immune and pruritic mechanisms associated with poison ivy ACD remain largely unexplored. Here, we compared skin whole transcriptomes and itch mediator levels in mouse ACD models induced by the poison ivy allergen, urushiol, and the synthetic allergen, oxazolone. The urushiol model produced a Th2-biased immune response and scratching behavior, resembling findings in poison ivy patients. Urushiol-challenged skin contained elevated levels of the cytokine thymic stromal lymphopoietin (TSLP), a T-cell regulator and itch mediator, and pruritogenic serotonin (5-HT) and endothelin (ET-1), but not substance P (SP) or histamine. The oxazolone model generated a mixed Th1/Th2 response associated with increased levels of substance P, 5-HT, ET-1, but not TSLP or histamine. Injections of a TSLP monoclonal neutralizing antibody, serotonergic or endothelin inhibitors, but not SP inhibitors or antihistamines, reduced scratching behaviors in urushiol-challenged mice. Our findings suggest that the mouse urushiol model may serve as a translational model of human poison ivy ACD study. Inhibiting signaling by TSLP and other cytokines may represent alternatives to the standard steroid/antihistamine regimen for steroid-resistant or -intolerant patients and in exaggerated systemic responses to poison ivy.

Indexed as

AllergensAnimalsCatecholsCytokinesDermatitis, ToxicodendronDisease Models, AnimalGene Expression ProfilingHumansInflammation MediatorsMaleMiceOxazolonePruritusSignal TransductionSkinTh2 CellsAllergensCatecholsCytokinesInflammation MediatorsOxazoloneThymic Stromal LymphopoietinurushiolCytokinesImmunologyNeurosciencePharmacology

Identifiers

PMID31184997
PMCPMC6675552
OpenAlexW2950958458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.